Literature DB >> 8037735

IL-10 inhibits HIV-1 replication and is induced by tat.

R Masood1, Y Lunardi-Iskandar, T Moudgil, Y Zhang, R E Law, C L Huang, R K Puri, A M Levine, P S Gill.   

Abstract

Interleukin 10 (IL-10) is produced by TH2 lymphocytes and regulates both lymphoid and myeloid cells. In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls. IL-10 mRNA was detectable in both monocytes/macrophages and T lymphocytes isolated from PBMCs of HIV infected patients. We have also shown that infection of promonocytic (U937) and T (H9) cell lines with HIV stimulates IL-10 secretion. Furthermore, a T cell line (H9) stably transfected with a HIV tat expression-vector secreted higher levels of IL-10. We have also demonstrated that rhIL-10 inhibited HIV-1 replication in infected monocytes and PBMCs in a dose dependent manner. IL-10 may thus participate in long latency between HIV-1 infection and development of AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037735     DOI: 10.1006/bbrc.1994.1938

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

2.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Type 2 cytokine serum levels in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu; P Wiley
Journal:  J Natl Med Assoc       Date:  1997-11       Impact factor: 1.798

Review 4.  Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.

Authors:  Aaron Christensen-Quick; Christophe Vanpouille; Andrea Lisco; Sara Gianella
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

5.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

6.  Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Authors:  A Blauvelt; C Chougnet; G M Shearer; S I Katz
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

7.  Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus.

Authors:  D Pyeon; K L O'Reilly; G A Splitter
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals.

Authors:  M D Galiani; E Aguado; R Tarazona; P Romero; I Molina; M Santamaria; R Solana; J Peña
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

9.  Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.

Authors:  Justine K Wong; Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

10.  Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients.

Authors:  F Diaz-Mitoma; A Kumar; S Karimi; M Kryworuchko; M P Daftarian; W D Creery; L G Filion; W Cameron
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.